niacinamide has been researched along with c-peptide in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barák, L; Jancová, E; Kolár, J; Michalková, D; Sílesová, J | 1 |
| Barbosa, JJ; Canafax, DM; Lewis, CM; Sprafka, JM | 1 |
| Butler-Simon, N; Chase, HP; Garg, S; Hoops, SL; McDuffie, M; O'Brien, D | 1 |
| Casamitjana, R; Gomis, R; Mendola, G | 1 |
| Bernal, M; Lassmann-Vague, V; Picq, R; Vague, P; Vialettes, B | 1 |
| Andreani, D; Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fava, D; Gragnoli, C; Pozzilli, P; Signore, A; Visalli, N | 1 |
| Andreani, D; Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fioriti, E; Lucentini, L; Pozzilli, P; Signore, A; Visalli, N | 1 |
| Beattie, GM; Hayek, A; Mally, MI; Otonkoski, T; Rubin, JS | 1 |
| Browne, PD; Kolb, H; Pozzilli, P | 1 |
| Pozzilli, P | 1 |
| Amoretti, R; Baroni, MG; Buzzetti, R; Cavallo, MG; Crinò, A; De Mattia, G; Faldetta, MR; Fiori, R; Fioriti, E; Giovannini, C; Lucentini, L; Matteoli, MC; Mesturino, C; Multari, G; Paci, F; Pisano, L; Pozzilli, P; Romiti, A; Signore, A; Sulli, N; Suppa, M; Suraci, C; Suraci, MT; Teodonio, C; Visalli, N | 1 |
| Polo, V; Pontiroli, AE; Saibene, A | 1 |
| Aguilera, E; Casamitjana, R; Conget, I; Fernández-Balsells, M; Gomis, R; Sesmilo, G; Vidal, J | 1 |
| Bonner-Weir, S; Lopez-Avalos, MD; Sharma, A; Tatarkiewicz, K; Weir, GC | 1 |
| Beretta Anguissola, G; Bizzarri, C; Corbi, S; Crinò, A; Manca Bitti, ML; Manfrini, S; Matteoli, MC; Mesturino, C; Patera, IP; Pitocco, D; Pozzilli, P; Schiaffini, R; Spera, S; Suraci, C; Visalli, N | 1 |
| Chang, CC; Ferber, S; Linning, KD; Madhukar, BV; Olson, LK; Reed, DN; Tai, MH; Trosko, JE | 1 |
| Buzzetti, R; Ciampalini, P; Costanza, F; Crinó, A; Fioriti, E; Guglielmi, C; Manfrini, S; Matteoli, MC; Patera, P; Pitocco, D; Pozzilli, P; Schiaffini, R; Spera, S; Suraci, MC; Visalli, N | 1 |
| Araujo, R; Bedoya, FJ; Berná, G; Carneiro, EM; Martín, F; Soria, B; Vaca, P | 1 |
| Alenzi, FQ | 1 |
| Maslinski, S; Mittal, TK; Rongies, W; Szewczyk, G; Szukiewicz, D | 1 |
| Maslinska, D; Pyzlak, M; Rongies, W; Stangret, A; Szukiewicz, D | 1 |
| Chujo, D; Fujita, Y; Kobayashi, N; Lamont, J; Levy, MF; Matsumoto, S; Naziruddin, B; Noguchi, H; Onaca, N; Shimoda, M; Takita, M; Tate, C | 1 |
| Christensen, B; Dollerup, OL; Gillum, MP; Hartmann, B; Holst, JJ; Jessen, N; Møller, N; Trammell, SAJ; Treebak, JT | 1 |
1 review(s) available for niacinamide and c-peptide
| Article | Year |
|---|---|
Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists.
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus, Type 1; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Niacinamide; Randomized Controlled Trials as Topic | 1996 |
13 trial(s) available for niacinamide and c-peptide
| Article | Year |
|---|---|
Double-blind randomized trial of nicotinamide on early-onset diabetes.
Topics: Blood Glucose Self-Monitoring; C-Peptide; Diabetes Mellitus, Type 1; Double-Blind Method; Glycated Hemoglobin; Humans; Niacinamide; Remission Induction | 1992 |
A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus.
Topics: Adolescent; C-Peptide; Child; Clinical Trials as Topic; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Niacinamide; Random Allocation | 1990 |
Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
Topics: Adolescent; Autoantibodies; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Female; Humans; Islets of Langerhans; Male; Niacinamide | 1989 |
Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; HLA-DR Antigens; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Niacinamide | 1989 |
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Niacinamide; Placebos; Time Factors | 1995 |
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Niacinamide; Pregnenediones | 1994 |
BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group.
Topics: Adolescent; BCG Vaccine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Follow-Up Studies; Glycated Hemoglobin; Humans; Injections, Intradermal; Insulin; Niacinamide; Remission Induction | 1997 |
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)
Topics: Adolescent; Adult; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Leukopenia; Niacinamide; Prospective Studies; Vitamin E | 1997 |
Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Niacinamide; Retreatment; Single-Blind Method; Sulfonylurea Compounds; Treatment Failure; Treatment Outcome | 1998 |
Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
Topics: Adult; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Female; Glutamate Decarboxylase; Humans; Injections, Intravenous; Insulin; Insulin Infusion Systems; Islets of Langerhans; Male; Niacinamide; Pilot Projects; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Time Factors | 2000 |
A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Topics: Adolescent; Aging; Antioxidants; C-Peptide; Child; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Niacinamide; Vitamin E | 2004 |
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus, Type 1; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Insulin; Male; Niacinamide; Retrospective Studies | 2005 |
Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity.
Topics: Blood Glucose; C-Peptide; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Niacinamide; Obesity; Pyridinium Compounds | 2019 |
9 other study(ies) available for niacinamide and c-peptide
| Article | Year |
|---|---|
[Early intensification of treatment in diabetes using a combination of insulin and nicotinamide--effect on C-peptide levels and the course of the disease].
Topics: C-Peptide; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Insulin; Niacinamide | 1992 |
Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact.
Topics: Abortion, Induced; Animals; C-Peptide; Cell Aggregation; Cell Communication; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Epithelial Cells; Epithelium; Extracellular Matrix; Female; Fetal Tissue Transplantation; Glucagon; Graft Survival; Hepatocyte Growth Factor; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Mice; Mice, Nude; Niacinamide; Pregnancy; Transcription, Genetic; Transplantation, Heterologous | 1996 |
Enhanced maturation of porcine neonatal pancreatic cell clusters with growth factors fails to improve transplantation outcome.
Topics: Animals; Animals, Newborn; Blood Glucose; C-Peptide; Cattle; Cell Culture Techniques; Culture Media; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucagon; Glucokinase; Glucose Transporter Type 2; Growth Substances; Humans; Insulin; Insulin-Like Growth Factor I; Islets of Langerhans; Islets of Langerhans Transplantation; Monosaccharide Transport Proteins; Niacinamide; Pancreas; Polymerase Chain Reaction; Recombinant Proteins; Somatostatin; Swine; Treatment Outcome | 2001 |
Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
Topics: Acetylcysteine; Adenoviridae; Adult; Albumins; alpha-Amylases; C-Peptide; Cell Aggregation; Cell Differentiation; Cell Separation; Cells, Cultured; Chromones; Culture Media; Culture Media, Serum-Free; Exenatide; Gene Expression Regulation; Genetic Vectors; Glucagon; Homeodomain Proteins; Humans; Insulin; Intermediate Filament Proteins; Intracellular Fluid; Islets of Langerhans; Morpholines; Nerve Tissue Proteins; Nestin; Niacinamide; Oxidation-Reduction; Peptides; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Stem Cells; Trans-Activators; Transcription Factors; Venoms; Vimentin | 2004 |
Nicotinamide induces differentiation of embryonic stem cells into insulin-secreting cells.
Topics: Animals; C-Peptide; Cell Differentiation; Cell Transplantation; Diabetes Mellitus, Experimental; Embryonic Stem Cells; Glucose; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin | 2008 |
Effect of nicotinamide on experimental induced diabetes.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Niacinamide; Nitrites; Rats; Rats, Sprague-Dawley | 2009 |
Involvement of histamine and histamine H2 receptors in nicotinamide-induced differentiation of human amniotic epithelial cells into insulin-producing cells.
Topics: Adult; Amniotic Fluid; C-Peptide; Cell Differentiation; Cells, Cultured; Cimetidine; Epithelial Cells; Female; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Insulin; Insulin-Secreting Cells; Niacinamide; Nicotinic Agonists; Pregnancy; Pyrilamine; Receptors, Histamine H2 | 2010 |
Decrease in expression of histamine H2 receptors by human amniotic epithelial cells during differentiation into pancreatic beta-like cells.
Topics: Amnion; C-Peptide; Cell Differentiation; Cell Shape; Cells, Cultured; Epithelial Cells; Female; Humans; Insulin-Secreting Cells; Niacinamide; Nicotinic Agonists; Pregnancy; Receptors, Histamine H1; Receptors, Histamine H2 | 2010 |
Improved pancreatic islet isolation outcome in autologous transplantation for chronic pancreatitis.
Topics: Adenosine; Adult; Allopurinol; Body Weight; C-Peptide; Epoprostenol; Female; Fluorocarbons; Follow-Up Studies; Glutamine; Glutathione; Humans; Hydroxyethyl Starch Derivatives; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Magnesium Sulfate; Male; Middle Aged; Niacinamide; Organ Preservation; Organ Preservation Solutions; Pancreatitis, Chronic; Raffinose; Transplantation, Autologous; Trehalose | 2012 |